Home LiteratureArticle Details
PMID: 8513594 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni.

Clinical immunology and immunopathology ·Vol. 68 ·No. 1 ·1993-07-00 ·Pages 57-63

Lukacs NW, Boros DL

Abstract

The pathology in schistosomiasis mansoni is primarily due to hepatic and intestinal granuloma formation around deposited eggs and subsequent fibrosis. The intensity of the granulomatous response is dependent on the lymphokines produced by T cells in response to soluble egg antigens (SEA). The present study examined the relationship of three inflammatory lymphokines, IL-2, IL-4, and IFN-gamma in granuloma formation during the acute stage of the murine infection. Repeated injections of anti-IL-2 or anti-IL-4 mAbs in vivo significantly diminished pulmonary granuloma formation in infected mice and demonstrated that both IL-2 and IL-4 were involved during the period of peak granuloma formation. Administration of anti-IL-2 mAb decreased IL-2, but not IL-4 production, while anti-IL-4 mAb treatment decreased both IL-2 and IL-4 production by splenic T cells. Administration of anti-IFN-gamma mAb to infected mice significantly increased pulmonary granuloma formation and increased the production of both IL-2 and IL-4 by splenic T cells. Repeated injections of graded doses of recombinant IFN-gamma given to mice between 6 and 8 weeks of infection decreased pulmonary granuloma formation as well as IL-2 and IL-4 production by splenic T cells. These data demonstrate that the regulation of lymphokines, IFN-gamma, IL-2, and IL-4, is important in influencing the intensity of granuloma formation. IL-2 and IL-4 appear to play a proinflammatory role in granuloma formation, while IFN-gamma may downregulate splenic IL-2 and IL-4 production and, more importantly, the corresponding inflammatory granuloma formation.

MeSH Terms
Animals Antibodies, Monoclonal/pharmacology Female Granuloma/immunology,prevention & control Interferon-gamma/pharmacology,physiology,therapeutic use Interleukin-2/pharmacology Interleukin-4/pharmacology Lymphokines/immunology,metabolism,pharmacology Mice Mice, Inbred CBA Recombinant Proteins/pharmacology,therapeutic use Schistosomiasis mansoni/drug therapy,immunology Spleen/cytology,metabolism
Chemicals
Antibodies, Monoclonal Interleukin-2 Lymphokines Recombinant Proteins Interleukin-4 Interferon-gamma
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lukacs N W
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602.
Boros D L
Article Info
Journal
Clinical immunology and immunopathology
Abbr.
Clin Immunol Immunopathol
ISSN
0090-1229
Published
1993-07-00
Pages
57-63
Language
English
Region
United States
NLM ID
0356637
Subset
IM
Grants
NIAID NIH HHS · AI-12913 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]